Health
Capricor Therapeutics Announces Closing Of Underwritten Public Offering And Full Exercise Of The Underwriters’ Option To Purchase Additional Shares
(MENAFN - GlobeNewsWire - Nasdaq) SAN DIEGO, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based ...
By: menafn
- Oct 19 2024
- 0
- 0 Views
ONLY AVAILABLE IN PAID PLANS